loadpatents
name:-0.10149812698364
name:-0.077315092086792
name:-0.020514011383057
Masuda; Esteban Patent Filings

Masuda; Esteban

Patent Applications and Registrations

Patent applications and USPTO patent grants for Masuda; Esteban.The latest application filed is for "compounds and method for treating autoimmune diseases".

Company Profile
21.86.107
  • Masuda; Esteban - Menlo Park CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds And Method For Treating Autoimmune Diseases
App 20220218705 - Masuda; Esteban ;   et al.
2022-07-14
RIP1 inhibitory compounds and methods for making and using the same
Grant 11,377,428 - Masuda , et al. July 5, 2
2022-07-05
RIP1 inhibitory compounds and methods for making and using the same
Grant 11,370,764 - Masuda , et al. June 28, 2
2022-06-28
RIP1 inhibitory compounds and methods for making and using the same
Grant 11,370,765 - Masuda , et al. June 28, 2
2022-06-28
RIP1 inhibitory compounds and methods for making and using the same
Grant 11,332,451 - Masuda , et al. May 17, 2
2022-05-17
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant RE48,898 - Bhamidipati , et al. January 25, 2
2022-01-25
Rip1k Inhibitors
App 20220009936 - BHMIDIPATI; Somasekhar ;   et al.
2022-01-13
Compounds and method for treating autoimmune diseases
Grant 11,220,496 - Masuda , et al. January 11, 2
2022-01-11
Method For Treatment Of Covid-19-associated Conditions
App 20210283152 - Masuda; Esteban ;   et al.
2021-09-16
Tyrosine kinase inhibitors
Grant 11,110,082 - Holland , et al. September 7, 2
2021-09-07
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210238153 - Masuda; Esteban ;   et al.
2021-08-05
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210214347 - Taylor; Vanessa ;   et al.
2021-07-15
RIP1 inhibitory compounds and methods for making and using the same
Grant 10,975,064 - Taylor , et al. April 13, 2
2021-04-13
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210040053 - Masuda; Esteban ;   et al.
2021-02-11
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210009537 - Masuda; Esteban ;   et al.
2021-01-14
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210002236 - Masuda; Esteban ;   et al.
2021-01-07
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20210002237 - Masuda; Esteban ;   et al.
2021-01-07
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20200407332 - Masuda; Esteban ;   et al.
2020-12-31
Method Of Preventing And Treating Thrombosis
App 20200377518 - Masuda; Esteban
2020-12-03
RIP1 inhibitory compounds and methods for making and using the same
Grant 10,815,206 - Masuda , et al. October 27, 2
2020-10-27
Protein kinase C inhibitors and uses thereof
Grant 10,792,282 - Singh , et al. October 6, 2
2020-10-06
Prodrugs Of 2,4-pyrimidinediamine Compounds And Their Uses
App 20200270271 - Singh; Rajinder ;   et al.
2020-08-27
Compounds And Method For Treating Autoimmune Diseases
App 20200087293 - Masuda; Esteban ;   et al.
2020-03-19
Tyrosine Kinase Inhibitors
App 20200078348 - Holland; Sacha ;   et al.
2020-03-12
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 10,577,381 - Singh , et al.
2020-03-03
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20200016179 - Bhamidipati; Somasekhar ;   et al.
2020-01-16
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20190337934 - Taylor; Vanessa ;   et al.
2019-11-07
Rip1 Inhibitory Compounds And Methods For Making And Using The Same
App 20190337907 - Masuda; Esteban ;   et al.
2019-11-07
Tyrosine kinase inhibitors
Grant 10,434,096 - Holland , et al. O
2019-10-08
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20190292197 - Singh; Rajinder ;   et al.
2019-09-26
Compounds and method for treating autoimmune diseases
Grant 10,414,758 - Masuda , et al. Sept
2019-09-17
Compositions And Methods For Inhibition Of The Jak Pathway
App 20190256476 - Argade; Ankush ;   et al.
2019-08-22
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 10,357,505 - Bhamidipati , et al. July 23, 2
2019-07-23
Tyrosine Kinase Inhibitors
App 20190099411 - Holland; Sacha ;   et al.
2019-04-04
Protein Kinase C Inhibitors and Uses Thereof
App 20190060310 - Singh; Rajinder ;   et al.
2019-02-28
Tyrosine kinase inhibitors
Grant 10,130,623 - Holland , et al. November 20, 2
2018-11-20
Protein kinase C inhibitors and uses thereof
Grant 10,005,777 - Singh , et al. June 26, 2
2018-06-26
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20180153912 - Bhamidipati; Somasekhar ;   et al.
2018-06-07
Compounds And Method For Treating Autoimmune Diseases
App 20180141938 - Masuda; Esteban ;   et al.
2018-05-24
Protein kinase C inhibitors and uses thereof
Grant 9,913,843 - Kolluri , et al. March 13, 2
2018-03-13
Compounds and method for treating autoimmune diseases
Grant 9,890,144 - Masuda , et al. February 13, 2
2018-02-13
Protein Kinase C Inhibitors and Uses Thereof
App 20180030050 - Singh; Rajinder ;   et al.
2018-02-01
Tyrosine Kinase Inhibitors
App 20180008589 - Holland; Sacha ;   et al.
2018-01-11
Protein Kinase C Inhibitors and Uses Thereof
App 20170360786 - Singh; Rajinder ;   et al.
2017-12-21
Kinase inhibitors and their uses
Grant 9,834,568 - Ding , et al. December 5, 2
2017-12-05
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20170291909 - Singh; Rajinder ;   et al.
2017-10-12
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 9,737,554 - Bhamidipati , et al. August 22, 2
2017-08-22
Protein kinase C inhibitors and uses thereof
Grant 9,682,976 - Singh , et al. June 20, 2
2017-06-20
Compositions And Methods For Inhibition Of The Jak Pathway
App 20170121291 - Argade; Ankush ;   et al.
2017-05-04
Compositions and methods for inhibition of the JAK pathway
Grant 9,593,082 - Argade , et al. March 14, 2
2017-03-14
Protein kinase C inhibitors and uses thereof
Grant 9,566,278 - Singh , et al. February 14, 2
2017-02-14
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 9,532,998 - Singh , et al. January 3, 2
2017-01-03
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20160367575 - Bhamidipati; Somasekhar ;   et al.
2016-12-22
Compositions and methods for inhibition of the JAK pathway
Grant 9,481,654 - Li , et al. November 1, 2
2016-11-01
Protein Kinase C Inhibitors and Uses Thereof
App 20160257681 - Singh; Rajinder ;   et al.
2016-09-08
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20160136191 - Singh; Rajinder ;   et al.
2016-05-19
Protein kinase C inhibitors and uses thereof
Grant 9,321,763 - Singh , et al. April 26, 2
2016-04-26
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 9,283,238 - Bhamidipati , et al. March 15, 2
2016-03-15
Protein Kinase C Inhibitors and Uses Thereof
App 20160058760 - Singh; Rajinder ;   et al.
2016-03-03
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 9,266,912 - Singh , et al. February 23, 2
2016-02-23
Kinase Inhibitors And Their Uses
App 20160024116 - Ding; Pingyu ;   et al.
2016-01-28
Protein kinase C inhibitors and uses thereof
Grant 9,181,222 - Holland , et al. November 10, 2
2015-11-10
Compounds And Method For Treating Autoimmune Diseases
App 20150313899 - Masuda; Esteban ;   et al.
2015-11-05
Protein Kinase C Inhibitors And Uses Thereof
App 20150306100 - Kolluri; Rao ;   et al.
2015-10-29
Protein kinase C inhibitors and uses thereof
Grant 9,169,249 - Singh , et al. October 27, 2
2015-10-27
Kinase inhibitors and their uses
Grant 9,096,542 - Ding , et al. August 4, 2
2015-08-04
Protein kinase C inhibitors and uses thereof
Grant 9,062,068 - Kolluri , et al. June 23, 2
2015-06-23
Compositions And Methods For Inhibition Of The Jak Pathway
App 20150158824 - Li; Hui ;   et al.
2015-06-11
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20150133404 - Bhamidipati; Somasekhar ;   et al.
2015-05-14
Compositions and methods for inhibition of the JAK pathway
Grant 8,962,643 - Li , et al. February 24, 2
2015-02-24
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,912,170 - Bhamidipati , et al. December 16, 2
2014-12-16
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20140357598 - Singh; Rajinder ;   et al.
2014-12-04
Protein Kinase C Inhibitors and Uses Thereof
App 20140329842 - Holland; Sacha ;   et al.
2014-11-06
Protein Kinase C Inhibitors and Uses Thereof
App 20140275055 - Singh; Rajinder ;   et al.
2014-09-18
Compounds And Method For Treating Autoimmune Diseases
App 20140213555 - Masuda; Esteban ;   et al.
2014-07-31
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,785,437 - Singh , et al. July 22, 2
2014-07-22
Protein Kinase C Inhibitors And Uses Thereof
App 20140163022 - Kolluri; Rao ;   et al.
2014-06-12
Protein kinase C inhibitors and uses thereof
Grant 8,710,223 - Holland , et al. April 29, 2
2014-04-29
Methods for inhibiting allograft rejection
Grant 8,637,038 - Taylor , et al. January 28, 2
2014-01-28
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20130338357 - Singh; Rajinder ;   et al.
2013-12-19
Protein Kinase C Inhibitors and Uses Thereof
App 20130331374 - Singh; Rajinder ;   et al.
2013-12-12
Method Of Treating Muscular Degradation
App 20130310340 - Payan; Donald G. ;   et al.
2013-11-21
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20130310341 - Bhamidipati; Somasekhar ;   et al.
2013-11-21
Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
Grant 8,575,165 - Gururaja , et al. November 5, 2
2013-11-05
Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
Grant 8,530,466 - Masuda , et al. September 10, 2
2013-09-10
Methods of treating cell proliferative disorders
Grant 8,481,521 - Masuda , et al. July 9, 2
2013-07-09
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,476,263 - Singh , et al. July 2, 2
2013-07-02
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,445,485 - Bhamidipati , et al. May 21, 2
2013-05-21
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
Grant 8,334,297 - Li , et al. December 18, 2
2012-12-18
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
Grant 8,314,093 - Clough , et al. November 20, 2
2012-11-20
Methods For Inhibiting Allograft Rejection
App 20120263737 - Taylor; Vanessa ;   et al.
2012-10-18
Methods of Treating Cell Proliferative Disorders
App 20120245127 - Masuda; Esteban ;   et al.
2012-09-27
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20120232036 - Singh; Rajinder ;   et al.
2012-09-13
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20120208785 - Bhamidipati; Somasekhar ;   et al.
2012-08-16
Methods of treating cell proliferative disorders
Grant 8,227,455 - Masuda , et al. July 24, 2
2012-07-24
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,211,888 - Singh , et al. July 3, 2
2012-07-03
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 8,163,902 - Bhamidipati , et al. April 24, 2
2012-04-24
Protein Kinase C Inhibitors And Uses Thereof
App 20120022092 - Holland; Sacha ;   et al.
2012-01-26
Kinase Inhibitors And Their Uses
App 20120015937 - Ding; Pingyu ;   et al.
2012-01-19
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
App 20110319613 - Singh; Rajinder ;   et al.
2011-12-29
Kinase inhibitors and their uses
Grant 8,053,434 - Ding , et al. November 8, 2
2011-11-08
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 7,989,448 - Singh , et al. August 2, 2
2011-08-02
Prodrugs Of 2,4-pyrimidinediamine Compounds And Their Uses
App 20110144059 - Bhamidipati; Somasekhar ;   et al.
2011-06-16
Compositions and methods for inhibition of the JAK pathway
Grant 7,915,273 - Argade , et al. March 29, 2
2011-03-29
Use of 2,4-Pyrimidinediamines For the Treatment of Atherosclerosis
App 20110046126 - Masuda; Esteban ;   et al.
2011-02-24
2,4-pyrimidinediamine Compounds For Treatment Of Inflammatory Disorders
App 20100179164 - Li; Hui ;   et al.
2010-07-15
Methods For Treating Inflammatory Disorders Using 2,4-pyrimidinediamine Compounds
App 20100179165 - Gururaja; Tarikere ;   et al.
2010-07-15
2,4-pyrimidinediamine Compounds For Treating Or Preventing Autoimmune Diseases
App 20100152172 - Clough; Jeffrey W. ;   et al.
2010-06-17
Compositions And Methods For Inhibition Of The Jak Pathway
App 20100152218 - Argade; Ankush ;   et al.
2010-06-17
Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
Grant 7,736,846 - Masuda , et al. June 15, 2
2010-06-15
Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
Grant 7,723,018 - Booher , et al. May 25, 2
2010-05-25
Kinase Inhibitors And Their Uses
App 20100069369 - Ding; Pingyu ;   et al.
2010-03-18
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
Grant 7,659,280 - Clough , et al. February 9, 2
2010-02-09
Method for identifying compounds that modulate RXR associated processes with IgE production
Grant 7,604,951 - Kinsella , et al. October 20, 2
2009-10-20
Kinase inhibitors and their uses
Grant 7,601,713 - Ding , et al. October 13, 2
2009-10-13
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
Grant 7,598,050 - Masuda , et al. October 6, 2
2009-10-06
Methods and compositions for treating degenerative bone disorders
Grant 7,576,053 - Masuda , et al. August 18, 2
2009-08-18
Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)
Grant 7,563,585 - Masuda , et al. July 21, 2
2009-07-21
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
Grant 7,538,108 - Singh , et al. May 26, 2
2009-05-26
Prodrugs Of 2,4-pyrimidinediamine Compounds And Their Uses
App 20090124580 - Singh; Rajinder ;   et al.
2009-05-14
EDG: modulators of lymphocyte activation and migration
Grant 7,521,192 - Liao , et al. April 21, 2
2009-04-21
EDG: Modulators of lymphocyte activation and migration
App 20080260719 - Liao; X. Charlene ;   et al.
2008-10-23
Compounds that modulate processes associated with IgE production
Grant 7,425,418 - Kinsella , et al. September 16, 2
2008-09-16
Compositions And Methods For Inhibition Of The Jak Pathway
App 20080221089 - Argade; Ankush ;   et al.
2008-09-11
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
Grant 7,422,867 - Masuda , et al. September 9, 2
2008-09-09
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
Grant 7,378,251 - Masuda , et al. May 27, 2
2008-05-27
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
Grant 7,374,894 - Masuda , et al. May 20, 2
2008-05-20
Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
Grant 7,371,537 - Vallone , et al. May 13, 2
2008-05-13
Methods Of Identifying Compounds That Modulate Il-4 Receptor-mediated Ige Synthesis Utilizing A Thioredoxin-like 32 Kda Protein
App 20080009076 - Masuda; Esteban ;   et al.
2008-01-10
Methods Of Identifying Compounds That Modulate Il-4 Receptor-mediated Ige Synthesis Utilizing An Adenosine Kinase
App 20080003620 - Masuda; Esteban ;   et al.
2008-01-03
Methods Of Identifying Compounds That Modulate Il-4 Receptor-mediated Ige Synthesis Utilizing A B-cell Associated Protein
App 20080003618 - MASUDA; Esteban ;   et al.
2008-01-03
Compounds That Modulate Processes Associated With Ige Production And Methods And Kits For Identifying And Using The Same
App 20070298440 - Kinsella; Todd M. ;   et al.
2007-12-27
Methods Of Identifying Compounds That Modulate Il-4 Receptor-mediated Ige Synthesis Utilizing A Chloride Intracellular Channel 1 Protein
App 20070298437 - Masuda; Esteban ;   et al.
2007-12-27
Methods Of Identifying Compounds That Modulate Il-4 Receptor-mediated Ige Synthesis Utilizing A C-myc Protein
App 20070244033 - MASUDA; Esteban ;   et al.
2007-10-18
Compositions And Methods For Inhibition Of The Jak Pathway
App 20070203161 - ARGADE; Ankush ;   et al.
2007-08-30
Compositions And Methods For Inhibition Of The Jak Pathway
App 20070203162 - Li; Hui ;   et al.
2007-08-30
2,4-pyrimidinediamine Compounds For Treating Or Preventing Autoimmune Diseases
App 20070197782 - CLOUGH; Jeffrey Wayne ;   et al.
2007-08-23
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
Grant 7,241,581 - Masuda , et al. July 10, 2
2007-07-10
Kinase Inhibitors And Their Uses
App 20070142402 - Ding; Pingyu ;   et al.
2007-06-21
Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein
App 20070135350 - Masuda; Esteban ;   et al.
2007-06-14
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
Grant 7,208,289 - Masuda , et al. April 24, 2
2007-04-24
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
Grant 7,189,523 - Masuda , et al. March 13, 2
2007-03-13
Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase
App 20070054862 - Masuda; Esteban ;   et al.
2007-03-08
Methods and compositions for treating degenerative bone disorders
App 20070004626 - Masuda; Esteban ;   et al.
2007-01-04
Methods of treating cell proliferative disorders
App 20060276459 - Masuda; Esteban ;   et al.
2006-12-07
Methods of screening cyclic peptides and identifying targets therefor
App 20060275832 - Masuda; Esteban
2006-12-07
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
Grant 7,141,434 - Masuda , et al. November 28, 2
2006-11-28
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
App 20060234983 - Singh; Rajinder ;   et al.
2006-10-19
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
App 20060211657 - Singh; Rajinder ;   et al.
2006-09-21
Methods and compositions for screening for altered cellular phenotypes
App 20060147978 - Lorens; James ;   et al.
2006-07-06
Modulators of leukocyte activation, Hck compositions and methods of use
Grant 7,067,266 - Friera , et al. June 27, 2
2006-06-27
Methods and compositions for screening for altered cellular phenotypes
Grant 7,056,687 - Lorens , et al. June 6, 2
2006-06-06
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
Grant 6,979,549 - Masuda , et al. December 27, 2
2005-12-27
Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
App 20050191719 - Vallone, Marcy K. ;   et al.
2005-09-01
Modulators of leukocyte activation, BIC compositions and methods of use
Grant 6,929,923 - Vallone , et al. August 16, 2
2005-08-16
Modulators of lymphocyte activation and migration
App 20050130117 - Davis, Cong Li ;   et al.
2005-06-16
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
App 20050112702 - Masuda, Esteban ;   et al.
2005-05-26
Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
Grant 6,890,725 - Vallone , et al. May 10, 2
2005-05-10
Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
App 20040180353 - Booher, Robert ;   et al.
2004-09-16
Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
App 20040116347 - Masuda, Esteban ;   et al.
2004-06-17
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a C-MYC protein
App 20040033538 - Masuda, Esteban ;   et al.
2004-02-19
Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
App 20040018567 - Vallone, Marcy K. ;   et al.
2004-01-29
Modulators of leukocyte activation, BIC compositions and methods of use
App 20040018566 - Vallone, Marcy K. ;   et al.
2004-01-29
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
App 20040014649 - Masuda, Esteban ;   et al.
2004-01-22
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
App 20040014149 - Masuda, Esteban ;   et al.
2004-01-22
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
App 20040014148 - Masuda, Esteban ;   et al.
2004-01-22
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
App 20040014147 - Masuda, Esteban ;   et al.
2004-01-22
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
App 20040014638 - Masuda, Esteban ;   et al.
2004-01-22
Modulators of leukocyte activation, Hck compositions and methods of use
App 20040009173 - Friera, Annabelle ;   et al.
2004-01-15
Methods of identifying target polypeptides
App 20030170724 - Anderson, David C. ;   et al.
2003-09-11
Compounds that modulate processes associated with IgE production and methods and kits for identifying and using the same
App 20030170738 - Kinsella, Todd M. ;   et al.
2003-09-11
GRB7: novel regulator of lymphocyte signaling
App 20030109440 - Chu, Peter ;   et al.
2003-06-12
Methods and compositions for screening for altered cellular phenotypes
App 20030022196 - Lorens, James ;   et al.
2003-01-30
EDG: modulators of lymphocyte activation and migration
App 20020155512 - Liao, X. Charlene ;   et al.
2002-10-24
TRAC1: modulators of lymphocyte activation
App 20020146747 - Masuda, Esteban ;   et al.
2002-10-10
Company Registrations
SEC0001686849Masuda Esteban

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed